Treatments with the neurotoxin botulinum toxin can be covered by public health insurance under certain circumstances. However, this does not usually include aesthetic indications such as anti-wrinkle injections. If, on the other hand, there are medical indications, the treatment can in many cases be covered by the public health insurance.
Botulinum toxin is a neurotoxin that is produced by anaerobic bacteria of the genus Clostridium botulinum in seven different serotypes from A to G. Subtype A is particularly used for numerous therapeutic purposes.
This toxin acts by inhibiting the transmission of excitation from nerve cells to other cells, especially muscle cells. Through the breakdown of protein complexes, the release of the neurotransmitter acetylcholine is blocked. As a result, the contraction of the muscle becomes weaker or fails completely, causing paralysis of the muscle. The duration of action of the drug is usually about 12 weeks.
The indications that are usually covered by public health insurance include the following:
If the compound is used for a purpose not listed in the compound's technical information, it is necessary to consult with the health insurance provider prior to treatment, as the reimbursement of costs is often individually assessed.